ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
-3.57%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$259M
AUM Growth
+$259M
(+2.1%)
Cap. Flow
-$465M
Cap. Flow
% of AUM
-179.55%
Top 10 Holdings %
Top 10 Hldgs %
60.28%
Holding
68
New
17
Increased
13
Reduced
17
Closed
19
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$13.9M |
| 2 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$13.8M |
| 3 |
HCA Healthcare
HCA
|
$12.8M |
| 4 |
Bristol-Myers Squibb
BMY
|
$10.4M |
| 5 |
Charles River Laboratories
CRL
|
$9.93M |
Top Sells
| 1 |
Takeda Pharmaceutical
TAK
|
$14.5M |
| 2 |
iRhythm Technologies
IRTC
|
$8.18M |
| 3 |
AVDR
Avedro, Inc Common Stock
AVDR
|
$7.03M |
| 4 |
Encompass Health
EHC
|
$6.52M |
| 5 |
VCRA
VOCERA COMMUNICATIONS, INC.
VCRA
|
$6.48M |
Sector Composition
| 1 | Healthcare | 82.5% |
| 2 | Industrials | 8.2% |
| 3 | Technology | 0.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RCM
1
DELISTED
R1 RCM Inc. Common Stock
RCM
| $21.2M | 7.62% | 2,378,963 +1,548,154 | +186% | +$13.8M |
|
2
Zimmer Biomet
ZBH
$21B
| $20.9M | 7.51% | 152,496 +42,864 | +39% | +$5.88M |
|
|
3
HCA Healthcare
HCA
$94.5B
| $18M | 6.47% | 149,755 +106,132 | +243% | +$12.8M |
|
|
OXFD
4
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $16.5M | 5.91% | 989,436 +360,200 | +57% | +$5.99M |
|
5
Labcorp
LH
$23.1B
| $14.9M | 5.37% | 88,983 +6,083 | +7% | +$1.02M |
|
|
6
Bristol-Myers Squibb
BMY
$96B
| $14.8M | 5.31% | 291,925 +205,628 | +238% | +$10.4M |
|
|
7
Johnson & Johnson
JNJ
$427B
| $13.9M | 4.99% | +107,413 | New | +$13.9M |
|
|
PRAH
8
DELISTED
PRA Health Sciences, Inc.
PRAH
| $12.6M | 4.52% | 126,809 +29,609 | +30% | +$2.94M |
|
9
AbbVie
ABBV
$372B
| $12.3M | 4.4% | 162,007 +72,999 | +82% | +$5.53M |
|
10
Cigna
CI
$80.3B
| $10.9M | 3.93% | 72,109 +10,519 | +17% | +$1.6M |
|
|
11
Charles River Laboratories
CRL
$8.04B
| $9.93M | 3.56% | +74,986 | New | +$9.93M |
|
12
Cencora
COR
$56.5B
| $8.69M | 3.12% | 105,501 +31,998 | +44% | +$2.63M |
|
13
Zoetis
ZTS
$69.3B
| $7.6M | 2.73% | +60,999 | New | +$7.6M |
|
|
WMGI
14
DELISTED
Wright Medical Group Inc
WMGI
| $6.22M | 2.23% | 301,391 -70,588 | -19% | -$1.46M |
|
15
Elevance Health
ELV
$71.8B
| $6.16M | 2.21% | +25,657 | New | +$6.16M |
|
16
Becton Dickinson
BDX
$55.3B
| $5.58M | 2% | +22,061 | New | +$5.58M |
|
17
Integra LifeSciences
IART
$1.18B
| $5.06M | 1.82% | 84,225 +41,398 | +97% | +$2.49M |
|
18
Haemonetics
HAE
$2.63B
| $4.11M | 1.48% | +32,594 | New | +$4.11M |
|
|
SIEN
19
DELISTED
Sientra, Inc.
SIEN
| $3.43M | 1.23% | 529,950 -755,905 | -59% | -$4.9M |
|
20
Sanofi
SNY
$121B
| $3.11M | 1.12% | 67,200 -53,414 | -44% | -$2.47M |
|
|
NCNA
21
NuCana
NCNA
$6.09M
| $2.79M | 1% | +384,700 | New | +$2.79M |
|
22
Fate Therapeutics
FATE
$120M
| $2.59M | 0.93% | +166,782 | New | +$2.59M |
|
23
Bio-Rad Laboratories Class A
BIO
$8.06B
| $2.3M | 0.83% | 6,910 +3,175 | +85% | +$1.06M |
|
|
GWPH
24
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $1.97M | 0.71% | 17,130 -1,080 | -6% | -$124K |
|
25
Aclaris Therapeutics
ACRS
$209M
| $1.91M | 0.69% | 1,769,785 +140,458 | +9% | +$152K |
|